Skip to main content
Equibles
XXII logo

XXII · 22nd Century Group, Inc. · Metrics

Track XXII — free

Use XXII with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research XXII.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.55 -0.38 (-19.69%) At close · Nov 6 Play latest call Q2 2026 earnings call transcript
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Given the Company's projected operating requirements and its existing cash and cash equivalents, there is substantial doubt about the Company's ability to continue as a going concern through one year following the date that the Condensed Consolidated Financial Statements are issued. Management's plans do not alleviate substantial doubt about the Company's ability to continue as a going concern through one year following the date that the Condensed Consolidated Financial Statements are issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$19,080
Shares
12,310
Volume · Nov 6 489.21K Avg daily vol (2 sessions) 421.91K

XXII metrics

59 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.55
Market cap
$19,080

Price action

23 metrics
Price change (1W)
—
Price change (30D)
—
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Annualized volatility (3M)
—
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
—
RSI (14D)
—
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Consumer Defensive
Industry
Tobacco
Shares outstanding
12,310

Valuation

12 metrics
P / E (TTM)
0.0
Trailing earnings · reciprocal yield 56,003,507.8%
PEG ratio
—
EV / revenue
3.8×
reciprocal yield 26.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
4.2×
reciprocal yield 23.5%
P / book
3.3
reciprocal yield 30.2%
FCF yield
-14.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-22

Profitability

9 metrics
Gross margin
45.0%
Operating margin
-85.0%
Trailing 12 months
Net margin
-27.0%
Gross profit (TTM)
$6.53M
Operating profit (TTM)
−$12.35M
Net income (TTM)
−$3.93M
Trailing 12 months
Diluted EPS (TTM)
$1,080,867.70
FCF margin
-60.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
$-2,138,824,857.87
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$35,550.35

Growth

11 metrics
Revenue growth YoY
-29.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$14.52M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+20,720.0%
Year over year · more shares
Revenue CAGR (3Y)
-24.3%
Revenue CAGR (5Y)
-9.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-21.1%
Return on assets
-15.0%
Debt / equity
0.0
Current ratio
2.6
EBITDA (TTM)
−$21.17M
Free cash flow (TTM)
−$8.75M
Quick ratio
1.9
Interest coverage
-21.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$6.44M
Latest balance sheet
Cash & equivalents
$6.06M
Total assets
$26.17M
Total debt
$708,000

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$8.36M
Capital expenditures (TTM)
$393,000
R&D (TTM)
$879,000
SG&A (TTM)
$8.49M
Stock compensation (TTM)
$796,000
R&D / revenue
6.1%
Stock compensation / revenue
5.5%

Ownership (13F)

9 metrics
13F filers
18
13F filer change QoQ
-5
Institutional ownership
5.3%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
15.5%
Private-fund adviser ownership
15.5%
Active holders' share change QoQ
+1,282.1%
Holder tenure
9.5
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
5.3%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
47 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1347858 CUSIP 90137F707 13F (30d) 19 filings 9 filers Visit website Investor relations